A six-week randomized , double-blind , cross-sectional study was performed in two arms : In group 1 , 20 patients received desloratadine ( 5 mg/d ) alone ; in group 2 , 20 patients received desloratadine ( 5 mg ) plus montelukast ( 10 mg ) combination therapy .